Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis
- PMID: 31989688
- DOI: 10.1111/jdv.16229
Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis
Abstract
Background: Clinical studies on psoriasis in adolescents have mainly been performed in patients with severe psoriasis. Population-based studies of clinical characteristics and risk factors for later cardiovascular and metabolic disease in children and adolescents are lacking.
Objectives: To examine the clinical characteristics of adolescents with psoriasis nested in a general population cohort. Furthermore, to investigate cardiovascular and metabolic risk factors in the adolescents with psoriasis compared to parentally predisposed and non-predisposed adolescents without psoriasis from the same birth cohort.
Methods: We identified adolescents with and without psoriasis using a nationwide general population birth cohort in Denmark. A clinical examination included skin inspection and scoring of psoriasis severity, completion of a questionnaire on psoriasis and comorbidities, physical measurements, and blood sampling. Participants also completed self-administered questionnaires on quality of life and mental health.
Results: We included 81 adolescents with psoriasis and 234 controls (110 with genetic predisposition for psoriasis and 124 without predisposition). Median age was 15.6 (13.5-18.5) years, and in those with active psoriasis, median Psoriasis Area and Severity Index score was 1.2 (0.1-11.4). The scalp was the most common site of psoriasis, both at debut and at time of examination. Diaper rash in infancy was more frequent in the psoriasis group. No significant differences regarding quality of life, anxiety and depression were found. More adolescents with psoriasis were obese (8.6% vs. 1.7%, P = 0.008), and physical measures of abdominal obesity were also significantly higher. HbA1c was significantly higher (31.55 vs. 30.81 mmol/mol, P = 0.048), while no differences were found for blood pressure, lipids or high-sensitivity C-reactive protein. In a subgroup analysis, this was evident in the non-predisposed psoriasis-free controls only.
Conclusions: Overall, adolescents with psoriasis from this general population had mild disease. Still, early markers of cardiovascular and metabolic disease were elevated.
© 2020 European Academy of Dermatology and Venereology.
Comment in
-
Commentary to "Clinical characteristics including cardiovascular and metabolic risk factors in adolescents with psoriasis" by C Blegvad et al.J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1387. doi: 10.1111/jdv.16697. J Eur Acad Dermatol Venereol. 2020. PMID: 32678515 No abstract available.
References
-
- Lønnberg AS, Skov L, Skytthe A, Kyvik KO, Pedersen OB, Thomsen SF. Heritability of psoriasis in a large twin sample. Br J Dermatol 2013; 169: 412-416.
-
- Harder E, Andersen A-MN, Kamper-Jørgensen M, Skov L. No increased risk of fetal death or prolonged time to pregnancy in women with psoriasis. J Invest Dermatol 2014; 134: 1747-1749.
-
- Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 205-212.
-
- Egeberg A, Skov L, Gislason GH, Thyssen JP, Mallbris L. Incidence and prevalence of psoriasis in Denmark. Acta Derm Venereol 2017; 97: 808-812.
-
- Randa H, Todberg T, Skov L, Larsen LS, Zachariae R. Health-related quality of life in children and adolescents with psoriasis: a systematic review and meta-analysis. Acta Derm Venereol 2017; 97: 555-563.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
